Selective Retina Therapy with Real-Time Feedback-Controlled Dosimetry for Treating Acute Idiopathic Central Serous Chorioretinopathy in Korean Patients

Abstract EN

Purpose.

To evaluate short-term treatment outcomes following selective retina therapy (SRT) with real-time feedback-controlled dosimetry in Korean patients with acute idiopathic central serous chorioretinopathy (CSC).

Methods.

Sixteen eyes (16 patients) with acute idiopathic CSC (symptom duration < 3 months) were included in this retrospective study.

All patients underwent a single session of SRT with real-time feedback-controlled dosimetry.

Best-corrected visual acuity (BCVA) and central foveal thickness (CFT) before and 3 months after treatment were examined and compared.

Results.

The logarithm of minimal angle of resolution BCVA was significantly better 3 months after treatment (0.16 ± 0.18) than at the time of diagnosis (0.27 ± 0.18, P=0.002).

Additionally, subretinal fluid had resolved in all 16 eyes 3 months after treatment and CFT was significantly lower 3 months after treatment (215.6 ± 17.9 μm) than at baseline (441.4 ± 124.8 μm, P<0.001).

No notable SRT-related complications were observed during the study period.

Conclusion.

The results of the present study suggest that SRT is a useful therapeutic option for patients with acute idiopathic CSC.

Further studies are required to better understand the long-term efficacy of this treatment.

This trial is registered with clinical trial registration number NCT03339856.